Huntington National Bank’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Huntington National Bank’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,250	Closed	–	–	3047
2021 Q4	$0	Buy	+1,250	New	–	﹤0.01%	2974
2019 Q1	–	Sell	-25,000	Closed	-$5K	–	2451
2018 Q4	$5K	Buy	+25,000	New	+$5K	﹤0.01%	1463
2016 Q3	–	Sell	-9,700	Closed	-$6K	–	1675
2016 Q2	$6K	Buy	+9,700	New	+$10.4K	﹤0.01%	1326

Other funds holding NWBO

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

AIP

Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

LDB

Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

ECM

Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

Huntington National Bank's NWBO Position: Q1 2022 in Review

Huntington National Bank sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2022, closing a stake of 1,250 shares.

Huntington National Bank first reported a position in NWBO in Q2 2016 and held it in 3 quarters. The position peaked at $6K in Q2 2016. 15 funds tracked by Wall St. Rank hold NWBO as of Q1 2022.

Huntington National Bank reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2022 after selling out during the quarter.
Huntington National Bank sold 1,250 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2022.
Huntington National Bank first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2016 and held it in 3 quarters.
Huntington National Bank's Northwest Biotherapeutics, Inc. Common stock position peaked at $6K in Q2 2016.
15 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2022.

Based on Huntington National Bank's 13F filing for Q1 2022, filed 10 May 2022.